$11.77
0.554.9%
마지막 업데이트: Nov 4, 5:00 PM
Benzinga
Benzinga
Benzinga
목요일, 11월 05
Benzinga
© 2026 Benzinga | All Rights Reserved
Vir Biotechnology (VIR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.76 | $0.88 | $0.38 | $-0.47 |
| Actual | $-0.57 | $0.47 | $-0.85 | $-0.31 |
| Surprise | +25.0% | -46.6% | -323.7% | +34.0% |
| Revenue | ||||
| Estimate | $1.2M | $229.7M | $122.5M | $19.4M |
| Actual | $-188000 | $238.9M | $-29000 | $64.1M |
| Surprise | -115.4% | +4.01% | -100.0% | +230.1% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.65 | $-0.66 | $-0.68 | $-0.68 |
| Revenue | ||||
| Consensus | $6.6M | — | — | — |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $-0.57 | $-0.76 | 25.0 % |
| Q2 | Aug 5, 2026 | $0.47 | $0.88 | -46.6 % |
| Q1 | May 6, 2026 | $-0.85 | $0.38 | -323.7 % |
| Q4 | Feb 23, 2026 | $-0.31 | $-0.47 | 34.0 % |
| 회계 분기 | 보고된 날짜 | 실제 수익 | 예상 수익 | 놀라다 % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $-188.00K | $1.22M | -115.4 % |
| Q2 | Aug 5, 2026 | $238.95M | $229.72M | 4.01 % |
| Q1 | May 6, 2026 | $-29.00K | $122.54M | -100.0 % |
| Q4 | Feb 23, 2026 | $64.07M | $19.41M | 230.1 % |